CONDENSED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in-Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024	38,665,583
Beginning balance at Dec. 31, 2024	$ 143,625
Ending balance (in shares) at Mar. 31, 2025	38,665,583
Ending balance at Mar. 31, 2025	$ 143,625
Beginning balance (in shares) at Dec. 31, 2024		2,090,945
Beginning balance at Dec. 31, 2024	$ (129,510)	$ 2	$ 838	$ (130,350)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercises of stock options (in shares)	87,549	87,549
Issuance of common stock upon exercises of stock options	$ 34		34
Stock-based compensation	152		152
Net loss	(5,375)			(5,375)
Ending balance (in shares) at Mar. 31, 2025		2,178,494
Ending balance at Mar. 31, 2025	$ (134,699)	$ 2	1,024	(135,725)
Beginning balance (in shares) at Dec. 31, 2025	0
Beginning balance at Dec. 31, 2025	$ 0
Ending balance (in shares) at Mar. 31, 2026	0
Ending balance at Mar. 31, 2026	$ 0
Beginning balance (in shares) at Dec. 31, 2025	46,865,051	46,865,051
Beginning balance at Dec. 31, 2025	$ 13,260	$ 47	168,878	(155,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon Private Placement, net of issuance cost (in shares)		2,867,089
Issuance of common stock upon Private Placement, net of issuance cost	$ 13,620	$ 3	13,617
Issuance of common stock upon exercises of stock options (in shares)	106,727	106,727
Issuance of common stock upon exercises of stock options	$ 39		39
Stock-based compensation	334		334
Net loss	$ (7,033)			(7,033)
Ending balance (in shares) at Mar. 31, 2026	49,838,867	49,838,867
Ending balance at Mar. 31, 2026	$ 20,220	$ 50	$ 182,868	$ (162,698)